Intervening on Metabolic Dysfunction-Associated Steatotic Liver Disease in Latino/a and Black Patients with Diabetes: A Feasibility Pilot
We demonstrated that a telehealth intervention designed to proactively deliver EBM of MASLD was feasible and acceptable in a cohort of Latino/a and Black patients with T2D. Opportunities existed to better align each participants' care with guideline-based care of MASLD.
Authors
- Matthew J. Crowley (ORCID: https://orcid.org/0000-0002-6205-4536)
- Alice Parish (ORCID: https://orcid.org/0000-0002-5775-0457)
- Bryan C. Batch (ORCID: https://orcid.org/0000-0002-7138-2064)
- Anastasia‐Stefania Alexopoulos (ORCID: https://orcid.org/0000-0002-0690-1526)
- Maren K. Olsen (ORCID: https://orcid.org/0000-0002-9540-2103)
- Susanne Danus
- Cynthia A. Moylan (ORCID: https://orcid.org/0000-0001-8454-7086)
- Connie R. Thacker
Institutions
- Duke University (US)
- Duke Medical Center (US)
- Durham VA Medical Center (US)
Publication Details
- Journal
- Diabetes Therapy
- Published
- 2024-09-14
- DOI
- https://doi.org/10.1007/s13300-024-01651-1
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Quality Enhancement Research Initiative
- National Center for Advancing Translational Sciences